Skip to main content

Poniard Pharmaceuticals, Inc. (PARD)

OTCMKTS: PARD · IEX Real-Time Price · USD
0.0100 0.0000 (0.00%)
Oct 18, 2021 9:30 AM EDT - Market open
Market Cap434,756
Revenue (ttm)n/a
Net Income (ttm)n/a
Shares Out1.50M
EPS (ttm)-3.79
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume0
Open0.0100
Previous Close0.0100
Day's Range0.0100 - 0.0100
52-Week Range0.0100 - 0.1200
Beta1.23
Analystsn/a
Price Targetn/a
Est. Earnings Daten/a

About PARD

Poniard Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of cancer therapeutics. Its lead platform product candidate includes Picoplatin, a platinum-based cancer therapy to treat multiple cancer indications, including small cell lung, colorectal, prostate, and ovarian cancers. The company has conducted a pivotal Phase III SPEAR trial of Picoplatin in the second-line treatment of patients with small cell lung cancer; Phase II trials evaluating picoplatin as a first-line treatment of metastatic ...

IndustryBiotechnology
IPO DateAug 11, 1988
Employees7
Stock ExchangeOTCMKTS
Ticker SymbolPARD
Full Company Profile

News

There is no news available yet.